The EU-funded WINTHER project will develop next-generation fast RSOM (F-RSOM) that is two orders of magnitude faster than the existing RSOM, enabling assessment of endothelial functions. The new RSOM will be aided by a modern computation framework, based on deterministic and artificial intelligence algorithms. It is hoped that the introduction of F-RSOM will improve the clinical accuracy of RSOM to advance its application in therapeutic monitoring of cardiometabolic diseases and inflammatory skin conditions.
Hybrid optical and optoacoustic endoscope for esophageal tracking
ESOTRAC aims to significantly improve the detection of early-stage esophageal cancer. The interdisciplinary, 5-country research team will develop an innovative endoscope that combines sensing of pathophysiological tissue signatures resolved by multi-spectral optoacoustic (photoacoustic) tomography (MSOT) with morphological disease signatures provided by optical coherence tomography (OCT).
The EU-funded project INNODERM will develop a novel optoacoustic device for earlier non-invasive skin cancer diagnosis. Driven by leading dermatologists and market leading SMEs in optoacoustic and ultrasound technology, INNODERM will design and prototype a handheld, portable, scalable, label-free RSOM device for point-of care dermatology applications. INNODERM brings together key photonic & ultrasound technologies and will validate the technical and economic viability of RSOM in dermatology suites for fast diagnosis and skin disease monitoring.